icon-folder.gif   Conference Reports for NATAP  
 
  EASL 2024
June 5-8, Milan, Italy
Back grey_arrow_rt.gif
 
 
 
Bulevirtide in combination with pegylated interferon alfa-2a
shows a sustained off-treatment response in the liver

 
 
  EASL 2024 June 5-8 Milan Italy
 
Lena Allweiss, Annika Volmari, Dmitry Manuilov, Stephan Urban, Heiner Wedemeyer, Wildaliz Nieves, Jeffrey J. Wallin, Renee-Claude Mercier, Audrey Lau, Maura Dandri

0612241

0612242

0612243

0612244

0612245

0612246

0612247

0612248